Fulvia M.
- Country
- Italy
- Department
- Malattie Infettive
Research Overview
- OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Study
- Evaluation of the Pharmacokinetics of Subcutaneous Administration of Piperacillin/Tazobactam: An Open-Label, Multicentric, Non-Inferiority Randomized Clinical Trial (STUPITA01)
Data & Insights
Has run more than one trial at 1 of 18 partner sites.
Specializations
Infectious Diseases and Antiviral Care
The investigator is involved in clinical research on infectious disease, with attention to COVID-19, pneumonia, and urinary tract infections, alongside broader antiviral strategies in vulnerable patients.
- COVID-19
- Pneumonia
- Urinary Tract Infections
Therapeutic interest also extends to infection management in patients with cystic fibrosis and persistent bacterial colonization.
Oncology and Hematologic Malignancies
Her research landscape includes a broad oncology portfolio spanning solid tumors and hematologic malignancies, with emphasis on lung cancer, bladder cancer, breast cancer, and aggressive lymphoma subtypes.
- Non-Small Cell Lung Cancer
- Bladder Cancer
- Diffuse Large B-cell Lymphoma
She is also active in studies of acute leukemia, multiple myeloma, myelodysplastic syndromes, and gastrointestinal stromal tumor, reflecting a strong therapeutic focus on cancer treatment innovation.
Neurology, Epilepsy, and Movement Disorders
The investigator contributes to research in multiple sclerosis, epilepsy, and Tourette’s disorder, with additional interest in difficult-to-control seizure disorders and demyelinating disease.
- Multiple Sclerosis
- Refractory Epilepsy
- Tourette’s Disorder
Her portfolio also includes refractory status epilepticus, Lennox-Gastaut syndrome, and developmental and epileptic encephalopathies.
Autoimmune, Inflammatory, and Rheumatologic Disease
She is engaged in therapeutic research for psoriatic arthritis, systemic lupus erythematosus, primary Sjogren’s disease, and other immune-mediated conditions, with a clear interest in inflammation-driven disease control.
- Psoriatic Arthritis
- Systemic Lupus Erythematosus
- Primary Sjogren’s Disease
Additional involvement includes idiopathic inflammatory myopathies, systemic sclerosis, eosinophilic granulomatosis with polyangiitis, and axial spondyloarthritis.
Cardiometabolic, Renal, and Respiratory Medicine
Her clinical trial activity also covers cardiovascular disease, chronic kidney disease, diabetes mellitus, and obesity, together with respiratory disorders such as asthma and bronchiectasis.
- Cardiovascular Disease
- Chronic Kidney Disease
- Asthma
This profile includes research in stroke prevention, IgA nephropathy, pulmonary arterial hypertension, and cystic fibrosis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.